Mackenzie Financial Corp Lowers Holdings in Agilent Technologies, Inc. $A

Mackenzie Financial Corp decreased its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 34.4% in the 2nd quarter, Holdings Channel.com reports. The fund owned 614,209 shares of the medical research company’s stock after selling 321,684 shares during the quarter. Mackenzie Financial Corp’s holdings in Agilent Technologies were worth $72,483,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the business. Stone House Investment Management LLC purchased a new stake in Agilent Technologies in the 1st quarter valued at about $30,000. Ransom Advisory Ltd purchased a new position in Agilent Technologies during the first quarter worth about $32,000. Central Pacific Bank Trust Division acquired a new stake in shares of Agilent Technologies during the second quarter valued at about $33,000. Zions Bancorporation National Association UT acquired a new stake in shares of Agilent Technologies during the first quarter valued at about $38,000. Finally, Costello Asset Management INC purchased a new stake in shares of Agilent Technologies in the 1st quarter valued at approximately $47,000. Institutional investors and hedge funds own 87.41% of the company’s stock.

Insiders Place Their Bets

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 911 shares of the firm’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total value of $130,491.64. Following the sale, the chief executive officer directly owned 32,058 shares in the company, valued at $4,591,987.92. This trade represents a 2.76% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.26% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on A shares. JPMorgan Chase & Co. increased their price objective on shares of Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Bank of America raised their price target on Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 25th. Barclays boosted their price objective on Agilent Technologies from $145.00 to $165.00 and gave the company an “equal weight” rating in a report on Tuesday, November 25th. Wells Fargo & Company increased their target price on Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 25th. Finally, Evercore ISI lifted their target price on Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a research report on Tuesday, October 7th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $161.08.

Agilent Technologies Stock Down 0.6%

Shares of NYSE:A opened at $153.48 on Friday. The firm’s 50 day moving average price is $142.44 and its 200 day moving average price is $126.77. The stock has a market cap of $43.51 billion, a price-to-earnings ratio of 36.03, a price-to-earnings-growth ratio of 4.67 and a beta of 1.29. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, topping the consensus estimate of $1.58 by $0.01. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.83 billion. During the same quarter in the previous year, the business posted $1.46 EPS. The firm’s revenue was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS. FY 2026 guidance at 5.860-6.000 EPS. As a group, equities research analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Investors of record on Tuesday, January 6th will be issued a $0.255 dividend. This represents a $1.02 annualized dividend and a yield of 0.7%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Tuesday, January 6th. Agilent Technologies’s dividend payout ratio is currently 22.32%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.